Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Pacira BioSciences Inc., 3 years.
Pacira BioSciences Inc.
Director
Cardiff Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 8, 2024 | Pacira BioSciences Inc. | Open-market sale | −90,000 | $30.60 | $2,754,000 |
| Mar 7, 2024 | Pacira BioSciences Inc. | Open-market sale | −28,257 | $30.81 | $870,598 |
| Mar 6, 2024 | Pacira BioSciences Inc. | Open-market sale | −1,066 | $29.67 | $31,628 |
| Dec 19, 2023 | Cardiff Oncology Inc. | Open-market purchase | +30,000 | $1.37 | $41,100 |
| Nov 10, 2023 | Cardiff Oncology Inc. | Open-market purchase | +22,950 | $0.98 | $22,491 |
| Jun 14, 2023 | Pacira BioSciences Inc. | Grant or award | +1,775 | — | — |
| May 11, 2023 | Pacira BioSciences Inc. | Option exercise | +7,000 | $29.90 | $209,300 |
| May 11, 2023 | Pacira BioSciences Inc. | Open-market sale | −5,015 | $41.78 | $209,527 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.